chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pfizer Covid 19 vaccine: hives/broke out in hives/received the shot on her right arm, but the hives spread on the left shoulder down the arm and forearm; she still has "lizard skin"; has nerve on back shoulder to side and back of arm to forearm to her thumb which is not spasming; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in right arm on 30Jan2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. Medical history included allergic to penicillin and bee stings. The patient's concomitant medications were not reported. The patient previously had flu vaccine and had a flu and shingles vaccine and had shingles for 3 weeks after she took the shingles vaccine. The patient received her first vaccine on 30Jan2021. On 31Jan2021, the patient ended up in ER with hives from the vaccine. She was told that she would be given Prednisone for hives but not to take it until Monday at noon. Stated that they wanted her to wait 48 hours after vaccine before she started it because it would cut it in half. She started Prednisone 40mg on Monday and did get a few more hives on Tuesday and Wednesday. She had the shot in her right arm, and all this happened on the left side of her back. She had a patch of hive of 5x6 to 8x8 on her back and on the back of her arm by her elbow and forearm. She put apple cider vinegar on her arms, and she did not itch anymore. Someone told her that this could be shingles. She stated that she got flu vaccine and got sick with flu and she took the shingles vaccine and got shingles. She could not stand in shower with the shingles but that she can with this, so she knows that it is not the shingles. The patient did not want to take the second shot on 20Feb2021 and wanted to know what Pfizer thinks. She does like to travel and hopes to soon so she wanted to know if not taking the shot could get a stipulation if they required two shots to travel. She has nerve on back shoulder to side and back of arm to forearm to her thumb which is not spasming, but she knows that it is there which came on in the past week (2021). She was on Prednisone 40 mg for 5 days and she still had hives (though they are diminishing). The patient stated that she still has "lizard skin". She received the shot on her right arm, but the hives spread on the left shoulder down the arm and forearm where she had shingles. Her ER doctor told her not to take the second dose and her primary care physician told her to wait and think about it. She is wondering if she should receive the second dose. The outcome of the event hives was not recovered while the other events was unknown.  Information on the Batch/Lot number has been requested.
Patient complained of not being able to see. Felt faint and lost consciousness for 1 minute, then regained consciousness.
Information has been received from a healthcare professional referring to a female patient of unknown age. In 2014, the patient received her first two doses of GARDASIL (dose, route, lot# and expiration date were unknown). On 19-APR-2016, the patient received her third dose of GARDASIL (dose, route, lot# and expiration date were unknown) in the reporter's office. No adverse symptoms were reported. Additional information has been requested.
tested positive for Covid; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for Covid) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002M21A, 030L20A, 031L20A and 034F21A) for COVID-19 vaccination.     The patient had no allergies. There was no history relating to mentioned adverse event and both Acute and Chronic illnesses at the time of vaccination.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In May 2022, the patient experienced COVID-19 (tested positive for Covid). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, COVID-19 (tested positive for Covid) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In May 2022, SARS-CoV-2 test: Positive.         Concomitant medications details were not reported by the reporter. Patient got COVID in May-2022 (11-14) shortly after she got the second booster dose. Patient took Paxlovid for 5 days felt better shortly.   This case was linked to US-MODERNATX, INC.-MOD-2022-672539 (E2B Linked Report). This case was linked to MOD-2022-672556 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-672539:Husband case
Developed tinnitus in left ear, which included severe vibrations and spasms in my ear on day 2 following booster shot of Pfizer vaccine.  I went to a ear, eye, throat specialist on day 4. A CT scan has been ordered. The doctor does not know the cause of my ear problems or if it is temporary or permanent.
pt recv vax 31OCT96 & 2NOV96 pt noticed red, hard, palm sized area around shot site, no pain or little pain;3NOV96 site began to resolve, on 4NOV cont to resolve;pt recv shot via pressurized gas gun;
This spontaneous report was received from a Radiologic Technologist refers to a unspecified number of patient's of unknown age and gender. The patient's pertinent medical history, drug reactions or allergies and concomitant therapies were not provided. On an unspecified dates, the unspecified number of patient's were vaccinated with improperly stored doses of M-M-R II therapy type rHA (lot# M004305 and expiry date unknown) (dosage regimen was unknown). No adverse effect reported. No product quality complaint was filed. This is one of several reports received from the same reporter. Additional information has been requested.
Narrative:  This 59-year-old female transferred to this hospital from the other facility. Her problems go back to the point at which she received the first of 2 vaccinations for COVID-19. She said that, after she received the first dose, she had several days of weakness, nausea, loss of appetite and malaise. She began to feel better, and decided to go through with the second vaccination. After that, she once again began to experience diffuse weakness, and she began to notice some sensory changes. Within a period of a few days, she had lost the ability to use her extremities due to weakness, and had diffuse numbness and paresthesias. At that point, she was transferred to the previous facility, where she underwent a battery of test. Though none of those were confirmatory, the clinical evidence pointed to Gillian Barre syndrome. She underwent a course of IVIG, and says that her strength and sensation began to improve soon after the last dose. At that point, she started working with therapy, and she has made some functional improvements. From a medical standpoint, her hospital course was otherwise fairly unremarkable. There was discussion in the last facility about the possibility of sending her home, but she vehemently disagreed. She lives alone, and said that she would not be able to function independently. She was transferred to the living center to focus on her functional deficits, and continue her medical care.
fever; migraines; Chills; This is a spontaneous report from a contactable consumer (patient). A 28-year-old female patient (Weight: 150 lbs, Height: 5'10) received first dose bnt162b2 (Batch Number: EL3248, expiry date: Apr2021), via an unspecified route of administration on 22Jan2021 at single dose for covid-19 immunization. Medical history included ongoing migraines. The patient's concomitant medications were not reported. The patient experienced chills in Jan2021, fever on 23Jan2021, migraines in Jan2021. Developed low grade fever (100.8) and chills after receiving the first dose of the Covid-19 vaccine. First does giving 22Jan2021. Fever started late evening 23Jan2021. Developed migraine approximately 6 hours after the shot. The patient underwent lab tests and procedures which included body temperature: low grade fever (100.8) an unspecified date. The outcome of events was unknown.  No follow up attempts are possible. No further information is expected.
chest pain; dizzy-headed; runny nose; slight headache; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Heart disorder and Lupus erythematosus. Concomitant products included CLONAZEPAM (KLONOPIN) for an unknown indication.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pain) (seriousness criterion hospitalization), DIZZINESS (dizzy-headed), RHINORRHOEA (runny nose) and HEADACHE (slight headache). At the time of the report, CHEST PAIN (chest pain), DIZZINESS (dizzy-headed), RHINORRHOEA (runny nose) and HEADACHE (slight headache) outcome was unknown.      Concomitant product included heart medication.  Treatment information included Tylenol.   This case was linked to MOD-2021-060644 (Patient Link).  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
3rd dose of MODERNA COVID VACCINE GIVEN 11/12/21, LOT #020F21A; pt to ED from a SNF (name of facility not in medical record) after a fall; found to be positive for COVID; no respiratory issues; dc'd back to SNF where pt passed away 30 days later
Information has been received from a osteopathy concerning a 15 year old female patient with amoxicillin allergy who on 15-AUG-2009 was vaccinated with the first dose of GARDASIL. There was no concomitant medication. On 15-OCT-2009 the patient was diagnosed with mononucleosis. Physician mentioned the patient was asymptomatic at the time of reporting. Unspecified laboratory tests were performed. The patient had sought medical attention via office visit. The outcome of the event was unknown. Additional information has been requested.
This spontaneous report as received from a nurse refers to an unknown patients of unknown age and gender. On an unknown date, the patients were orally vaccinated with improperly stored doses of ROTATEQ (dose was not reported, lot # M029919 with expiration date: 13-JUN-2018). No adverse effects were reported. Data logger was involved. There was a previous temperature excursion. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1705USA004592: US-009507513-1705USA004589: US-009507513-1705USA004591: US-009507513-1704USA004333.
4hr p/vax pt would not stop crying;(this baby never cries);crying x 3hr went to MD ofc;pt fell asleep w/episode of staring & hand jerking then slept for 16hr straight;given APAP then motrin as prescribed;
Patient received vaccine on 3/31/21. Patient was admitted to our Special Care Unit 4/18/21 with Massive Bilateral Pulmonary Embolism- 1st Episode. She is currently on a Heparin drip.  She has been on OC for 5 years with no history of clotting. Patient reported left rib pain starting 4/16/21 and worsening, prompting her ED visit. She reports having the same symptoms on the right side 2 weeks prior (approx 4/5/21).
67 yo female with PMH of HTN, DM who has two days of left sided numbness that has progressed to left hemiparesis and dysarthria in the setting of having received the Johnson and Johnson vaccine on Wednesday(48hours prior). Patient was found to have a right parietal multifocal parenchymal hemorrhage measuring 19x36x37mm and small right temporal lobe SAH. Subsequent CTA showed thrombosis of the superior sagittal sinus and the right frontoparietal cortical veins as well has nonocclusive thrombus of right transverse and sigmoid sinus. The patient was also noted to have focal seizure of mouth and tongue and was loaded with phosphenytoin. After discussing case with neurology, nuero IR, NSGY and family it was decided to transfer the patient to sunrise for close monitoring and consideration of cerebral venous sinus thrombectomy if she worsens. I had a long discussion with multiple sisters about the risks of anticoagulation with argatroban given the IPH but the necessity given the cerebral venous thrombosis. I also discussed that argatroban is not readily reversible and that heparin is contraindicated if there is concern about vaccine induced thrombotic thrombocytopenia due to possible PF4 ab related to HIT. The patients VITT modified 4T score is 4 and she is intermediate risk for this being VITT. #Right parietal IPH, right temporal SAH and Superior saggital sinus thrombosis with nonocclusive thrombus of right transverse and sigmoid sinus -concern for vaccine induced thrombotic thrombocytopenia given johnson and johnson vaccine 2 days prior -modified VITT 4T score of 4- intermediate -send fibrinogen, d dimer, consider IVIG 1gm/kg per day for two days if high dimer, low fibrinogen and falling platelets -will start argatroban, avoid heparin until HIT ab (PF4) is resulted, if HIT positive avoid heparin -neuro IR consulted for possible IR intervention if worsens -transfer accepted by sunrise ICU, appreciate transfer for IR evaluation -continue phosphenytoin -SBP goal <150 with nicardipine and esmolol gtts -monitor daily fibrinogen, dimer, coags #AKI- monitoring uop and cr, consider renal US if worsens #DM- ISS #HTN- nicardipine and esmolol gtts for SBP <150, target 140 Patient seen, examined, labs and imaging reviewed, agree with resident note
Patient states that she had vomitting, diarrhea, and fever the night that she received the vaccine.
I had my vaccine on 12/30/2020 and in 01/07/2021 I had redness, swelling and a rash at the injection site. I also had pain and my arm felt warm
Two weeks subsequent to vaccination developed left facial Bell's Palsy.  Also, still has significant left arm local reaction.
Information has been received from a bachelor of science in nursing concerning her 5 year old daughter who in 1995 was vaccinated with VARIVAX. In 2000 the patient experienced a severe case of chickenpox. Later the patient experienced shingles. On an unspecified date the patient recovered from chickenpox and shingles. The patient sought unspecified medical attention at the physician's office. This is one of several reports from the same source. Additional information has been requested.
First had flu mist 2007 and started having severe symptoms of severe headache on back of head and then left side of head and neck.  Burning, painful sensation along occipital nerve area on left side. Symptoms lasted 4-6 months.  2007 received flu shot and had minor symptoms.  Had flu mist again 2008 and started symptoms all over again same area and type but not as severe as first year.  Saw 2 neurologists and ear-nost-throat specialist who could not find cause.  Did suggest occipital neuralgia.
patient states extremely hot and thirsty, knees locked up when he tried to stand and walk, had significant brain fog.  patient notified md. patient states as of today 10/2 he is slowly improving
Two or three minutes after getting the vaccine I felt dizzy, shortness of breath and fainted. The hospital emergency team assisted me with oxygen and on the Urgent Care Unit an EKG, and sugar tests were done.
heart attack; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (heart attack) in a male patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYOCARDIAL INFARCTION (heart attack) (seriousness criteria death and medically significant). The cause of death was not reported. It is unknown if an autopsy was performed.            No concomitant medication information was reported. No treatment medication information was reported.  Company Comment: This spontaneous case concerns a male patient of unknown age, with no medical history reported, who experienced a fatal unexpected serious (medically Significant) of Myocardial Infarction 2 days after receiving a dose of mRNA-1273.222 vaccine. The details of previous doses were not provided. The cause of death was reported as died of natural causes. Death occurred on an unknown date. It is unknown if an autopsy was performed. There was no information provided about the patient's age, underlying medical conditions, concomitant medications, clinical course of the event, associated symptoms, final diagnosis, diagnostic and treatment details. The benefit-risk relationship of mRNA-1273.222 vaccine, is not affected by this report. This case was linked to MODERNATX, INC.-MOD-2022-670450 (E2B Linked Report).; Sender's Comments: This spontaneous case concerns a male patient of unknown age, with no medical history reported, who experienced a fatal unexpected serious (medically Significant) of Myocardial Infarction 2 days after receiving a dose of mRNA-1273.222 vaccine. The details of previous doses were not provided. The cause of death was reported as died of natural causes. Death occurred on an unknown date. It is unknown if an autopsy was performed. There was no information provided about the patient's age, underlying medical conditions, concomitant medications, clinical course of the event, associated symptoms, final diagnosis, diagnostic and treatment details. The benefit-risk relationship of mRNA-1273.222 vaccine, is not affected by this report. MODERNATX, INC.-MOD-2022-670450:MOD-2022-670450 (Case for male patient); Reported Cause(s) of Death: Died of natural causes.
urticarial generalized 48 hrs p/3rd vax w/myalgia, arthralgias, fever & h/a;
This is a spontaneous report from a contactable consumer reporting for herself. A female patient of an unspecified age and ethnicity received PREVNAR 13, via an unspecified route of administration on an unspecified date at single dose for immunisation. Medical history included asthma ongoing. The patient's concomitant medications includes Budesonide/Formoterol inhaler were not reported.  The patient experienced flu-like symptoms with runny nose, chills, congestion, sore throat, "scratchy" ears on an unspecified date, four days after vaccination with outcome of unknown.
More than 35 days after the first dose without receiving the second dose; She was sick; had a cold; she got tired; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (More than 35 days after the first dose without receiving the second dose), ILLNESS (She was sick), NASOPHARYNGITIS (had a cold) and FATIGUE (she got tired) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD and Kidney disorder (She has kidney problems since 1 year).    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced FATIGUE (she got tired). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (More than 35 days after the first dose without receiving the second dose), ILLNESS (She was sick) and NASOPHARYNGITIS (had a cold). On 23-Mar-2021, FATIGUE (she got tired) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (More than 35 days after the first dose without receiving the second dose), ILLNESS (She was sick) and NASOPHARYNGITIS (had a cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient stated that she was sick and could not assist to the second dose. She stated that she had a cold which she usually has as she has COPD, and she has many conditions and it was horrible for her to go out of her house.  She stated that she may have a surgery on Monday, or maybe not.  Patient reported that she takes 16 concomitant medications for her conditions. No treatment information was provided.
Pain, and soreness, redness, rash, swelling at site of PNEUMOVAX injection (left arm). Patient went to the ER the following day treated and released. Told she had a allergic reaction to the shot.
Vaccine received on 1/7/21. Joint pain, nausea, gastric reflux started on 1/9/21. Generalized hives started on 1/11/21. Symptoms improved with Zofran, Pepcid and Benadryl.  Symptoms resolved on 1/15/21. Patient had a history of COVID 19 virus infection in October 2020.
Within one day after administration in my left arm, a large area of redness and swelling appeared and continued for about a week. At that time, my left arm began to tingle from shoulder to fingers. At first, about three or four times a day and at peak about 10 times a day, ( peak about two weeks) and gradually fewer per day over the course of more than two months.
Pt was administered second Moderna vaccine at 12:55 pm. Pt stood up from seated position at 1:01 pm and fell to floor, unresponsive to touch, verbal commands, noxious stimuli, and sternal rub. O2 satting at 86%, normal HR, at time of fall. At 1:02 RRT was initiated at Health Center. At 1:03, 911 was called. At 1:07, pt had no pulse or respirations for 30 seconds, during which 20x compressions were administered and AED shock was not advised. ROSC at 1:08, unable to obtain VS. Paramedics responded within 10 minutes and took pt to Emergency Room
The pt developed an area 18cm X 21cm of redness and induration on left upper arm.
pt recvd vax & 18DEC92 4PM started to get rash on hands; seen by MD who gave DPH; 19DEC92 awoke w/swollen hands & feet; rash all over body; still taking Pred & DPH; 20DEC92 hands & face started to swell; pruritus got uncontrollable;
Patient felt sick the Monday after receiving the vaccine after the patient completed her dialysis treatment. She experienced fever, chills, and achiness. She later developed diarrhea. She is still experiencing symptoms.
Fever, chills, headache set in about 14 hours after injection.  Symptoms were mostly resolved within 48 hours.
Patient received her second Covid Vaccine on 4/1/22.  Patient states, three days after receiving her Covid Vaccine, she started experiencing some numbness to her right arm.  Patient was seen on  4/5/22.  Per Dr., patient had some temperature sensation and some sensory sensation to pin prick.  Advised by MD to take Alleve one tablet twice daily.
PATIENT RECEIVED VACCINE THAT EXPERIENCED A TEMPERATURE EXCURSION, VACCINE WAS KEPT IN THE REFRIGERATOR FOR MORE THAN 30 DAYS. PATIENT STATED SHE WAS SICK FOR WEEK AND A HALF WITH A FEVER 100 - 102 DEGREES FARENHIGHT. PATIENT STATED SHE ALSO EXPERIENCED NON-STOP NAUSEA/VOMITING.